<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35581586</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-4598</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecular cancer</Title>
          <ISOAbbreviation>Mol Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Noncoding RNAs related to the hedgehog pathway in cancer: clinical implications and future perspectives.</ArticleTitle>
        <Pagination>
          <StartPage>115</StartPage>
          <MedlinePgn>115</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">115</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12943-022-01591-z</ELocationID>
        <Abstract>
          <AbstractText>Cancer is a type of malignant affliction threatening human health worldwide; however, the molecular mechanism of cancer pathogenesis remains to be elusive. The oncogenic hedgehog (Hh) pathway is a highly evolutionarily conserved signaling pathway in which the hedgehog-Patched complex is internalized to cellular lysosomes for degradation, resulting in the release of Smoothened inhibition and producing downstream intracellular signals. Noncoding RNAs (ncRNAs) with diversified regulatory functions have the potency of controlling cellular processes. Compelling evidence reveals that Hh pathway, ncRNAs, or their crosstalk play complicated roles in the initiation, metastasis, apoptosis and drug resistance of cancer, allowing ncRNAs related to the Hh pathway to serve as clinical biomarkers for targeted cancer therapy. In this review, we attempt to depict the multiple patterns of ncRNAs in the progression of malignant tumors via interactions with the Hh crucial elements in order to better understand the complex regulatory mechanism, and focus on Hh associated ncRNA therapeutics aimed at boosting their application in the clinical setting.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Song</LastName>
            <ForeName>Jia</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, 110122, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ge</LastName>
            <ForeName>Yuexin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, 110122, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Xiaoyu</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, 110122, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Qiutong</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, 110122, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gong</LastName>
            <ForeName>Shiqiang</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, 110122, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wei</LastName>
            <ForeName>Minjie</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, 110122, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shenyang Kangwei Medical Laboratory Analysis Co. LTD, Shenyang, 110000, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Niu</LastName>
            <ForeName>Jumin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gynecology, Shenyang Women's and Children's Hospital, Shenyang, 110011, People's Republic of China. niujumin@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, People's Republic of China. lzhao@cmu.edu.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, 110122, People's Republic of China. lzhao@cmu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Mol Cancer</MedlineTA>
        <NlmUniqueID>101147698</NlmUniqueID>
        <ISSNLinking>1476-4598</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D022661">RNA, Untranslated</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="Y">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D022661" MajorTopicYN="N">RNA, Untranslated</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Biomarker</Keyword>
        <Keyword MajorTopicYN="N">Cancer</Keyword>
        <Keyword MajorTopicYN="N">Hedgehog pathway</Keyword>
        <Keyword MajorTopicYN="N">NcRNAs</Keyword>
        <Keyword MajorTopicYN="N">Targeted therapy</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>17</Day>
          <Hour>23</Hour>
          <Minute>38</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35581586</ArticleId>
        <ArticleId IdType="pmc">PMC9112456</ArticleId>
        <ArticleId IdType="doi">10.1186/s12943-022-01591-z</ArticleId>
        <ArticleId IdType="pii">10.1186/s12943-022-01591-z</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>McMillan R, Matsui W. Molecular pathways: the hedgehog signaling pathway in cancer. Clin Cancer Res. 2012;18:4883–4888. doi: 10.1158/1078-0432.CCR-11-2509.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-11-2509</ArticleId>
            <ArticleId IdType="pmc">PMC3445776</ArticleId>
            <ArticleId IdType="pubmed">22718857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salaritabar A, Berindan-Neagoe I, Darvish B, Hadjiakhoondi F, Manayi A, Devi KP, et al.  Targeting hedgehog signaling pathway: paving the road for cancer therapy. Pharmacol Res. 2019;141:466–480. doi: 10.1016/j.phrs.2019.01.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.phrs.2019.01.014</ArticleId>
            <ArticleId IdType="pubmed">30639373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan L, Pepicelli CV, Dibble CC, Catbagan W, Zarycki JL, Laciak R, et al.  Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology. 2004;145:3961–3970. doi: 10.1210/en.2004-0079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2004-0079</ArticleId>
            <ArticleId IdType="pubmed">15132968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peacock CD, Wang Q, Gesell GS, Corcoran-Schwartz IM, Jones E, Kim J, et al.  Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci U S A. 2007;104:4048–4053. doi: 10.1073/pnas.0611682104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0611682104</ArticleId>
            <ArticleId IdType="pmc">PMC1805487</ArticleId>
            <ArticleId IdType="pubmed">17360475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature. 2004;431:931–45.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009;23:1494–1504. doi: 10.1101/gad.1800909.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1800909</ArticleId>
            <ArticleId IdType="pmc">PMC3152381</ArticleId>
            <ArticleId IdType="pubmed">19571179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74.</Citation>
        </Reference>
        <Reference>
          <Citation>Qin X, Zhou M, Lv H, Mao X, Li X, Guo H, et al.  Long noncoding RNA LINC00657 inhibits cervical cancer development by sponging miR-20a-5p and targeting RUNX3. Cancer Lett. 2021;498:130–141. doi: 10.1016/j.canlet.2020.10.044.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canlet.2020.10.044</ArticleId>
            <ArticleId IdType="pubmed">33129959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu L, Li N, Sun L, Zheng D, Shao G. Non-coding RNAs: the key detectors and regulators in cardiovascular disease. Genomics. 2021;113:1233–1246. doi: 10.1016/j.ygeno.2020.10.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ygeno.2020.10.024</ArticleId>
            <ArticleId IdType="pubmed">33164830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Zhang X, Cai B, Li Y, Jiang Y, Fu X, et al.  The long noncoding RNA lncCIRBIL disrupts the nuclear translocation of Bclaf1 alleviating cardiac ischemia-reperfusion injury. Nat Commun. 2021;12:522. doi: 10.1038/s41467-020-20844-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-020-20844-3</ArticleId>
            <ArticleId IdType="pmc">PMC7822959</ArticleId>
            <ArticleId IdType="pubmed">33483496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lauretti E, Dabrowski K, Praticò D. The neurobiology of non-coding RNAs and Alzheimer's disease pathogenesis: pathways, mechanisms and translational opportunities. Ageing Res Rev. 2021;71:101425. doi: 10.1016/j.arr.2021.101425.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.arr.2021.101425</ArticleId>
            <ArticleId IdType="pubmed">34384901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayes EL, Lewis-Wambi JS. Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA. Breast Cancer Res. 2015;17:40. doi: 10.1186/s13058-015-0542-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13058-015-0542-y</ArticleId>
            <ArticleId IdType="pmc">PMC4362832</ArticleId>
            <ArticleId IdType="pubmed">25849966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Li G, Guo X, Yao H, Wang G, Li C. Non-coding RNA in bladder cancer. Cancer Lett. 2020;485:38–44. doi: 10.1016/j.canlet.2020.04.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canlet.2020.04.023</ArticleId>
            <ArticleId IdType="pubmed">32437725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes Dev. 2008;22:2454–2472. doi: 10.1101/gad.1693608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1693608</ArticleId>
            <ArticleId IdType="pubmed">18794343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nüsslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in drosophila. Nature. 1980;287:795–801. doi: 10.1038/287795a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/287795a0</ArticleId>
            <ArticleId IdType="pubmed">6776413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammerschmidt M, Brook A, McMahon AP. The world according to hedgehog. Trends Genet. 1997;13:14–21. doi: 10.1016/S0168-9525(96)10051-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0168-9525(96)10051-2</ArticleId>
            <ArticleId IdType="pubmed">9009843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang DT, López A, von Kessler DP, Chiang C, Simandl BK, Zhao R, et al.  Products, genetic linkage and limb patterning activity of a murine hedgehog gene. Development. 1994;120:3339–3353. doi: 10.1242/dev.120.11.3339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.120.11.3339</ArticleId>
            <ArticleId IdType="pubmed">7720571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimeld SM. The evolution of the hedgehog gene family in chordates: insights from amphioxus hedgehog. Dev Genes Evol. 1999;209:40–47. doi: 10.1007/s004270050225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s004270050225</ArticleId>
            <ArticleId IdType="pubmed">9914417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muenke M, Beachy PA. Genetics of ventral forebrain development and holoprosencephaly. Curr Opin Genet Dev. 2000;10:262–269. doi: 10.1016/S0959-437X(00)00084-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0959-437X(00)00084-8</ArticleId>
            <ArticleId IdType="pubmed">10826992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li XL, Wang P, Xie Y. Protease nexin-1 protects against Alzheimer's disease by regulating the sonic hedgehog signaling pathway. Int J Neurosci. 2021;131:1087–1096. doi: 10.1080/00207454.2020.1773821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00207454.2020.1773821</ArticleId>
            <ArticleId IdType="pubmed">32449865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foulkes WD, Kamihara J, Evans DGR, Brugières L, Bourdeaut F, Molenaar JJ, et al.  Cancer surveillance in Gorlin syndrome and Rhabdoid tumor predisposition syndrome. Clin Cancer Res. 2017;23:e62–e67. doi: 10.1158/1078-0432.CCR-17-0595.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-17-0595</ArticleId>
            <ArticleId IdType="pmc">PMC7309678</ArticleId>
            <ArticleId IdType="pubmed">28620006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin AC, Hung HC, Chen YW, Cheng KP, Li CH, Lin CH, et al. Elevated hedgehog-interacting protein levels in subjects with Prediabetes and type 2 diabetes. J Clin Med. 2019;8:1635.</Citation>
        </Reference>
        <Reference>
          <Citation>Ahmad A, Maitah MY, Ginnebaugh KR, Li Y, Bao B, Gadgeel SM, et al.  Inhibition of hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs. J Hematol Oncol. 2013;6:77. doi: 10.1186/1756-8722-6-77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1756-8722-6-77</ArticleId>
            <ArticleId IdType="pmc">PMC3852827</ArticleId>
            <ArticleId IdType="pubmed">24199791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sasaki H, Nishizaki Y, Hui C, Nakafuku M, Kondoh H. Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. Development. 1999;126:3915–3924. doi: 10.1242/dev.126.17.3915.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.126.17.3915</ArticleId>
            <ArticleId IdType="pubmed">10433919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chuang PT, McMahon AP. Vertebrate hedgehog signalling modulated by induction of a hedgehog-binding protein. Nature. 1999;397:617–621. doi: 10.1038/17611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/17611</ArticleId>
            <ArticleId IdType="pubmed">10050855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh BN, Koyano-Nakagawa N, Gong W, Moskowitz IP, Weaver CV, Braunlin E, et al.  A conserved HH-Gli1-Mycn network regulates heart regeneration from newt to human. Nat Commun. 2018;9:4237. doi: 10.1038/s41467-018-06617-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-018-06617-z</ArticleId>
            <ArticleId IdType="pmc">PMC6185975</ArticleId>
            <ArticleId IdType="pubmed">30315164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li L, Ma TT, Ma YH, Jiang YF. LncRNA HCG18 contributes to nasopharyngeal carcinoma development by modulating miR-140/CCND1 and hedgehog signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23:10387–10399.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31841193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki H, Kumar SA, Shuai S, Diaz-Navarro A, Gutierrez-Fernandez A, De Antonellis P, et al.  Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma. Nature. 2019;574:707–711. doi: 10.1038/s41586-019-1650-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-019-1650-0</ArticleId>
            <ArticleId IdType="pmc">PMC7141958</ArticleId>
            <ArticleId IdType="pubmed">31664194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duman-Scheel M, Weng L, Xin S, Du W. Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E. Nature. 2002;417:299–304. doi: 10.1038/417299a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/417299a</ArticleId>
            <ArticleId IdType="pubmed">12015606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Philpott MP, et al.  Activation of the BCL2 promoter in response to hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res. 2004;64:7724–7731. doi: 10.1158/0008-5472.CAN-04-1085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-04-1085</ArticleId>
            <ArticleId IdType="pubmed">15520176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kong Y, Peng Y, Liu Y, Xin H, Zhan X, Tan W. Twist1 and snail link hedgehog signaling to tumor-initiating cell-like properties and acquired chemoresistance independently of ABC transporters. Stem Cells. 2015;33:1063–1074. doi: 10.1002/stem.1955.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.1955</ArticleId>
            <ArticleId IdType="pubmed">25588661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korshunov A, Okonechnikov K, Stichel D, Ryzhova M, Schrimpf D, Sahm F, et al.  Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicator. Neuro-Oncology. 2021;23:1576–1585. doi: 10.1093/neuonc/noab031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/neuonc/noab031</ArticleId>
            <ArticleId IdType="pmc">PMC8408884</ArticleId>
            <ArticleId IdType="pubmed">33589929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang J, Hui CC. Hedgehog signaling in development and cancer. Dev Cell. 2008;15:801–812. doi: 10.1016/j.devcel.2008.11.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2008.11.010</ArticleId>
            <ArticleId IdType="pmc">PMC6443374</ArticleId>
            <ArticleId IdType="pubmed">19081070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Briscoe J, Thérond PP. The mechanisms of hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol. 2013;14:416–429. doi: 10.1038/nrm3598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3598</ArticleId>
            <ArticleId IdType="pubmed">23719536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deshpande I, Liang J, Hedeen D, Roberts KJ, Zhang Y, Ha B, et al.  Smoothened stimulation by membrane sterols drives hedgehog pathway activity. Nature. 2019;571:284–288. doi: 10.1038/s41586-019-1355-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-019-1355-4</ArticleId>
            <ArticleId IdType="pmc">PMC6709672</ArticleId>
            <ArticleId IdType="pubmed">31263273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang P, Nedelcu D, Watanabe M, Jao C, Kim Y, Liu J, et al.  Cellular cholesterol directly activates smoothened in hedgehog signaling. Cell. 2016;166:1176–87.e14. doi: 10.1016/j.cell.2016.08.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2016.08.003</ArticleId>
            <ArticleId IdType="pmc">PMC5035717</ArticleId>
            <ArticleId IdType="pubmed">27545348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radhakrishnan A, Rohatgi R, Siebold C. Cholesterol access in cellular membranes controls hedgehog signaling. Nat Chem Biol. 2020;16:1303–1313. doi: 10.1038/s41589-020-00678-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41589-020-00678-2</ArticleId>
            <ArticleId IdType="pmc">PMC7872078</ArticleId>
            <ArticleId IdType="pubmed">33199907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mastronardi FG, Dimitroulakos J, Kamel-Reid S, Manoukian AS. Co-localization of patched and activated sonic hedgehog to lysosomes in neurons. Neuroreport. 2000;11:581–585. doi: 10.1097/00001756-200002280-00030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00001756-200002280-00030</ArticleId>
            <ArticleId IdType="pubmed">10718318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tukachinsky H, Lopez LV, Salic A. A mechanism for vertebrate hedgehog signaling: recruitment to cilia and dissociation of SuFu-Gli protein complexes. J Cell Biol. 2010;191:415–428. doi: 10.1083/jcb.201004108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201004108</ArticleId>
            <ArticleId IdType="pmc">PMC2958481</ArticleId>
            <ArticleId IdType="pubmed">20956384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalderon D. Transducing the hedgehog signal. Cell. 2000;103:371–374. doi: 10.1016/S0092-8674(00)00129-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(00)00129-X</ArticleId>
            <ArticleId IdType="pubmed">11081624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W, Ren XR, Nelson CD, Barak LS, Chen JK, Beachy PA, et al.  Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2. Science. 2004;306:2257–2260. doi: 10.1126/science.1104135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1104135</ArticleId>
            <ArticleId IdType="pubmed">15618519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rohatgi R, Milenkovic L, Scott MP. Patched1 regulates hedgehog signaling at the primary cilium. Science. 2007;317:372–376. doi: 10.1126/science.1139740.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1139740</ArticleId>
            <ArticleId IdType="pubmed">17641202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu X, Xiao S, Zhang M, Yang L, Zhong J, Li B, et al.  A novel protein encoded by circular SMO RNA is essential for hedgehog signaling activation and glioblastoma tumorigenicity. Genome Biol. 2021;22:33. doi: 10.1186/s13059-020-02250-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13059-020-02250-6</ArticleId>
            <ArticleId IdType="pmc">PMC7807754</ArticleId>
            <ArticleId IdType="pubmed">33446260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skoda AM, Simovic D, Karin V, Kardum V, Vranic S, Serman L. The role of the hedgehog signaling pathway in cancer: A comprehensive review. Bosn J Basic Med Sci. 2018;18:8–20. doi: 10.17305/bjbms.2018.2756.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.17305/bjbms.2018.2756</ArticleId>
            <ArticleId IdType="pmc">PMC5826678</ArticleId>
            <ArticleId IdType="pubmed">29274272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bailey JM, Mohr AM, Hollingsworth MA. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene. 2009;28:3513–3525. doi: 10.1038/onc.2009.220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2009.220</ArticleId>
            <ArticleId IdType="pmc">PMC2910592</ArticleId>
            <ArticleId IdType="pubmed">19633682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giroux-Leprieur E, Costantini A, Ding VW, He B. Hedgehog signaling in lung cancer: from Oncogenesis to cancer treatment resistance. Int J Mol Sci. 2018;19:2835.</Citation>
        </Reference>
        <Reference>
          <Citation>Szkandera J, Kiesslich T, Haybaeck J, Gerger A, Pichler M. Hedgehog signaling pathway in ovarian cancer. Int J Mol Sci. 2013;14:1179–1196. doi: 10.3390/ijms14011179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms14011179</ArticleId>
            <ArticleId IdType="pmc">PMC3565315</ArticleId>
            <ArticleId IdType="pubmed">23303278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monkkonen T, Lewis MT. New paradigms for the hedgehog signaling network in mammary gland development and breast cancer. Biochim Biophys Acta Rev Cancer. 2017;1868:315–332. doi: 10.1016/j.bbcan.2017.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbcan.2017.06.003</ArticleId>
            <ArticleId IdType="pmc">PMC5567999</ArticleId>
            <ArticleId IdType="pubmed">28624497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma X, Sheng T, Zhang Y, Zhang X, He J, Huang S, et al.  Hedgehog signaling is activated in subsets of esophageal cancers. Int J Cancer. 2006;118:139–148. doi: 10.1002/ijc.21295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.21295</ArticleId>
            <ArticleId IdType="pubmed">16003737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu X, Yang X, Zhao L. Indian hedgehog, a neglected member of hedgehog pathway, may offer a novel avenue for colorectal cancer therapy. Cancer Biother Radiopharm. 2009;24:733–735. doi: 10.1089/cbr.2009.0683.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cbr.2009.0683</ArticleId>
            <ArticleId IdType="pubmed">19954298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubin LL, de Sauvage FJ. Targeting the hedgehog pathway in cancer. Nat Rev Drug Discov. 2006;5:1026–1033. doi: 10.1038/nrd2086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd2086</ArticleId>
            <ArticleId IdType="pubmed">17139287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reifenberger J, Wolter M, Knobbe CB, Köhler B, Schönicke A, Scharwächter C, et al.  Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol. 2005;152:43–51. doi: 10.1111/j.1365-2133.2005.06353.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2133.2005.06353.x</ArticleId>
            <ArticleId IdType="pubmed">15656799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al.  Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 1996;272:1668–1671. doi: 10.1126/science.272.5268.1668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.272.5268.1668</ArticleId>
            <ArticleId IdType="pubmed">8658145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G. Mutations in the human homologue of the drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1997;57:2581–2585.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9205058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raffel C, Jenkins RB, Frederick L, Hebrink D, Alderete B, Fults DW, et al.  Sporadic medulloblastomas contain PTCH mutations. Cancer Res. 1997;57:842–845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9041183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGarvey TW, Maruta Y, Tomaszewski JE, Linnenbach AJ, Malkowicz SB. PTCH gene mutations in invasive transitional cell carcinoma of the bladder. Oncogene. 1998;17:1167–1172. doi: 10.1038/sj.onc.1202045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1202045</ArticleId>
            <ArticleId IdType="pubmed">9764827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, et al.  Activating smoothened mutations in sporadic basal-cell carcinoma. Nature. 1998;391:90–92. doi: 10.1038/34201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/34201</ArticleId>
            <ArticleId IdType="pubmed">9422511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reifenberger J, Wolter M, Weber RG, Megahed M, Ruzicka T, Lichter P, et al.  Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1998;58:1798–1803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9581815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, et al.  Mutations in SUFU predispose to medulloblastoma. Nat Genet. 2002;31:306–310. doi: 10.1038/ng916.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng916</ArticleId>
            <ArticleId IdType="pubmed">12068298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ertao Z, Jianhui C, Chuangqi C, Changjiang Q, Sile C, Yulong H, et al.  Autocrine sonic hedgehog signaling promotes gastric cancer proliferation through induction of phospholipase Cγ1 and the ERK1/2 pathway. J Exp Clin Cancer Res. 2016;35:63. doi: 10.1186/s13046-016-0336-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13046-016-0336-9</ArticleId>
            <ArticleId IdType="pmc">PMC4818860</ArticleId>
            <ArticleId IdType="pubmed">27039174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, et al.  Widespread requirement for hedgehog ligand stimulation in growth of digestive tract tumours. Nature. 2003;425:846–851. doi: 10.1038/nature01972.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature01972</ArticleId>
            <ArticleId IdType="pubmed">14520411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez P, Hernández AM, Stecca B, Kahler AJ, DeGueme AM, Barrett A, et al.  Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci U S A. 2004;101:12561–12566. doi: 10.1073/pnas.0404956101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0404956101</ArticleId>
            <ArticleId IdType="pmc">PMC514658</ArticleId>
            <ArticleId IdType="pubmed">15314219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Z, Xu J, He J, Zheng Y, Li H, Lu Y, et al.  A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance. Blood. 2014;124:2061–2071. doi: 10.1182/blood-2014-03-557298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2014-03-557298</ArticleId>
            <ArticleId IdType="pmc">PMC4186536</ArticleId>
            <ArticleId IdType="pubmed">25049282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Becher OJ, Hambardzumyan D, Fomchenko EI, Momota H, Mainwaring L, Bleau AM, et al.  Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas. Cancer Res. 2008;68:2241–2249. doi: 10.1158/0008-5472.CAN-07-6350.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-07-6350</ArticleId>
            <ArticleId IdType="pubmed">18381430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P, et al.  Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med. 2009;1:338–351. doi: 10.1002/emmm.200900039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/emmm.200900039</ArticleId>
            <ArticleId IdType="pmc">PMC3378144</ArticleId>
            <ArticleId IdType="pubmed">20049737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gulino A, Ferretti E, De Smaele E. Hedgehog signalling in colon cancer and stem cells. EMBO Mol Med. 2009;1:300–302. doi: 10.1002/emmm.200900042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/emmm.200900042</ArticleId>
            <ArticleId IdType="pmc">PMC3378148</ArticleId>
            <ArticleId IdType="pubmed">20049733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, et al.  A paracrine requirement for hedgehog signalling in cancer. Nature. 2008;455:406–410. doi: 10.1038/nature07275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature07275</ArticleId>
            <ArticleId IdType="pubmed">18754008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Theunissen JW, de Sauvage FJ. Paracrine hedgehog signaling in cancer. Cancer Res. 2009;69:6007–6010. doi: 10.1158/0008-5472.CAN-09-0756.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-09-0756</ArticleId>
            <ArticleId IdType="pubmed">19638582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei R, Lv M, Li F, Cheng T, Zhang Z, Jiang G, et al.  Human CAFs promote lymphangiogenesis in ovarian cancer via the Hh-VEGF-C signaling axis. Oncotarget. 2017;8:67315–67328. doi: 10.18632/oncotarget.18621.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.18621</ArticleId>
            <ArticleId IdType="pmc">PMC5620175</ArticleId>
            <ArticleId IdType="pubmed">28978035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan IS, Guy CD, Chen Y, Lu J, Swiderska-Syn M, Michelotti GA, et al.  Paracrine hedgehog signaling drives metabolic changes in hepatocellular carcinoma. Cancer Res. 2012;72:6344–6350. doi: 10.1158/0008-5472.CAN-12-1068.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-12-1068</ArticleId>
            <ArticleId IdType="pmc">PMC3525764</ArticleId>
            <ArticleId IdType="pubmed">23066040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cazet AS, Hui MN, Elsworth BL, Wu SZ, Roden D, Chan CL, et al.  Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer. Nat Commun. 2018;9:2897. doi: 10.1038/s41467-018-05220-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-018-05220-6</ArticleId>
            <ArticleId IdType="pmc">PMC6057940</ArticleId>
            <ArticleId IdType="pubmed">30042390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dierks C, Grbic J, Zirlik K, Beigi R, Englund NP, Guo GR, et al.  Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med. 2007;13:944–951. doi: 10.1038/nm1614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1614</ArticleId>
            <ArticleId IdType="pubmed">17632527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730–737. doi: 10.1038/nm0797-730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm0797-730</ArticleId>
            <ArticleId IdType="pubmed">9212098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al.  Cancer stem cells--perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006;66:9339–9344. doi: 10.1158/0008-5472.CAN-06-3126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-06-3126</ArticleId>
            <ArticleId IdType="pubmed">16990346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim BR, Na YJ, Kim JL, Jeong YA, Park SH, Jo MJ, et al.  RUNX3 suppresses metastasis and stemness by inhibiting hedgehog signaling in colorectal cancer. Cell Death Differ. 2020;27:676–694. doi: 10.1038/s41418-019-0379-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41418-019-0379-5</ArticleId>
            <ArticleId IdType="pmc">PMC7205901</ArticleId>
            <ArticleId IdType="pubmed">31278361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol. 2007;17:165–172. doi: 10.1016/j.cub.2006.11.033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cub.2006.11.033</ArticleId>
            <ArticleId IdType="pmc">PMC1855204</ArticleId>
            <ArticleId IdType="pubmed">17196391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, et al.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006;66:6063–6071. doi: 10.1158/0008-5472.CAN-06-0054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-06-0054</ArticleId>
            <ArticleId IdType="pmc">PMC4386278</ArticleId>
            <ArticleId IdType="pubmed">16778178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou M, Hou Y, Yang G, Zhang H, Tu G, Du YE, et al.  LncRNA-Hh strengthen cancer stem cells generation in twist-positive breast cancer via activation of hedgehog signaling pathway. Stem Cells. 2016;34:55–66. doi: 10.1002/stem.2219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.2219</ArticleId>
            <ArticleId IdType="pmc">PMC4832137</ArticleId>
            <ArticleId IdType="pubmed">26418365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32:453–461. doi: 10.1038/nbt.2890.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nbt.2890</ArticleId>
            <ArticleId IdType="pmc">PMC4121655</ArticleId>
            <ArticleId IdType="pubmed">24811520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12:381–388. doi: 10.1080/15476286.2015.1020271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15476286.2015.1020271</ArticleId>
            <ArticleId IdType="pmc">PMC4615371</ArticleId>
            <ArticleId IdType="pubmed">25746834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki H, Zuo Y, Wang J, Zhang MQ, Malhotra A, Mayeda A. Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res. 2006;34:e63. doi: 10.1093/nar/gkl151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkl151</ArticleId>
            <ArticleId IdType="pmc">PMC1458517</ArticleId>
            <ArticleId IdType="pubmed">16682442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al.  Circular RNAs are abundant, conserved, and associated with ALU repeats. Rna. 2013;19:141–157. doi: 10.1261/rna.035667.112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1261/rna.035667.112</ArticleId>
            <ArticleId IdType="pmc">PMC3543092</ArticleId>
            <ArticleId IdType="pubmed">23249747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, et al.  Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333–338. doi: 10.1038/nature11928.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11928</ArticleId>
            <ArticleId IdType="pubmed">23446348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ivanov A, Memczak S, Wyler E, Torti F, Porath HT, Orejuela MR, et al.  Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep. 2015;10:170–177. doi: 10.1016/j.celrep.2014.12.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.12.019</ArticleId>
            <ArticleId IdType="pubmed">25558066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675–691. doi: 10.1038/s41576-019-0158-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41576-019-0158-7</ArticleId>
            <ArticleId IdType="pubmed">31395983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang J, Yu L, Yan J, Xiao Y, Li W, Xiao J, et al.  Circular RNA DGKB promotes the progression of neuroblastoma by targeting miR-873/GLI1 Axis. Front Oncol. 2020;10:1104. doi: 10.3389/fonc.2020.01104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2020.01104</ArticleId>
            <ArticleId IdType="pmc">PMC7390925</ArticleId>
            <ArticleId IdType="pubmed">32793474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He Y, Huang H, Jin L, Zhang F, Zeng M, Wei L, et al.  CircZNF609 enhances hepatocellular carcinoma cell proliferation, metastasis, and stemness by activating the hedgehog pathway through the regulation of miR-15a-5p/15b-5p and GLI2 expressions. Cell Death Dis. 2020;11:358. doi: 10.1038/s41419-020-2441-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-020-2441-0</ArticleId>
            <ArticleId IdType="pmc">PMC7217914</ArticleId>
            <ArticleId IdType="pubmed">32398664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu L, Xia J, Yang J, Shi Y, Xia H, Xiang X, et al.  Circ-ZNF609 promotes migration of colorectal cancer by inhibiting Gli1 expression via microRNA-150. J Buon. 2018;23:1343–1349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30570857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiong Z, Zhou C, Wang L, Zhu R, Zhong L, Wan D, et al.  Circular RNA SMO sponges miR-338-3p to promote the growth of glioma by enhancing the expression of SMO. Aging (Albany NY) 2019;11:12345–12360. doi: 10.18632/aging.102576.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/aging.102576</ArticleId>
            <ArticleId IdType="pmc">PMC6949074</ArticleId>
            <ArticleId IdType="pubmed">31895689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y, Song J, Liu Y, Zhou Z, Wang X. Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2. J Exp Clin Cancer Res. 2020;39:101. doi: 10.1186/s13046-020-01598-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13046-020-01598-8</ArticleId>
            <ArticleId IdType="pmc">PMC7268652</ArticleId>
            <ArticleId IdType="pubmed">32493490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L, Li B, Yi X, Xiao X, Zheng Q, Ma L. Circ_0036412 affects the proliferation and cell cycle of hepatocellular carcinoma via hedgehog signaling pathway. J Transl Med. 2022;20:154. doi: 10.1186/s12967-022-03305-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12967-022-03305-x</ArticleId>
            <ArticleId IdType="pmc">PMC8981839</ArticleId>
            <ArticleId IdType="pubmed">35382824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye G, Pan R, Zhu L, Zhou D. Circ_DCAF6 potentiates cell stemness and growth in breast cancer through GLI1-hedgehog pathway. Exp Mol Pathol. 2020;116:104492. doi: 10.1016/j.yexmp.2020.104492.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yexmp.2020.104492</ArticleId>
            <ArticleId IdType="pubmed">32668286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J, Zhou X, Yang J, Sun Q, Liu Y, Li N, et al.  Circ-GLI1 promotes metastasis in melanoma through interacting with p70S6K2 to activate hedgehog/GLI1 and Wnt/β-catenin pathways and upregulate Cyr61. Cell Death Dis. 2020;11:596. doi: 10.1038/s41419-020-02799-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-020-02799-x</ArticleId>
            <ArticleId IdType="pmc">PMC7393080</ArticleId>
            <ArticleId IdType="pubmed">32732916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu Y, Wang Y, He L, Zhang J, Zhu X, Liu N, et al.  Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via hedgehog signaling. Mol Cancer. 2021;20:132. doi: 10.1186/s12943-021-01435-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12943-021-01435-2</ArticleId>
            <ArticleId IdType="pmc">PMC8515748</ArticleId>
            <ArticleId IdType="pubmed">34649567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berezikov E, Cuppen E, Plasterk RH. Approaches to microRNA discovery. Nat Genet. 2006;38 Suppl:S2–S7. doi: 10.1038/ng1794.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng1794</ArticleId>
            <ArticleId IdType="pubmed">16736019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–854. doi: 10.1016/0092-8674(93)90529-Y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(93)90529-Y</ArticleId>
            <ArticleId IdType="pubmed">8252621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993;75:855–862. doi: 10.1016/0092-8674(93)90530-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(93)90530-4</ArticleId>
            <ArticleId IdType="pubmed">8252622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203–222. doi: 10.1038/nrd.2016.246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd.2016.246</ArticleId>
            <ArticleId IdType="pubmed">28209991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abu-Izneid T, AlHajri N, Ibrahim AM, Javed MN, Salem KM, Pottoo FH, et al.  Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections. J Adv Res. 2021;30:133–145. doi: 10.1016/j.jare.2020.11.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jare.2020.11.013</ArticleId>
            <ArticleId IdType="pmc">PMC7708232</ArticleId>
            <ArticleId IdType="pubmed">33282419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song JH, Tieu AH, Cheng Y, Ma K, Akshintala VS, Simsek C, et al. Novel Long noncoding RNA miR205HG functions as an esophageal tumor-suppressive hedgehog inhibitor. Cancers (Basel). 2021;13:1707.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang YZ, Han JJ, Fan SQ, Yang W, Zhang YB, Xu TJ, et al.  miR-132 weakens proliferation and invasion of glioma cells via the inhibition of Gli1. Eur Rev Med Pharmacol Sci. 2018;22:1971–1978.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29687851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du W, Liu X, Chen L, Dou Z, Lei X, Chang L, et al.  Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemness. Neuro-Oncology. 2015;17:243–253. doi: 10.1093/neuonc/nou217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/neuonc/nou217</ArticleId>
            <ArticleId IdType="pmc">PMC4288524</ArticleId>
            <ArticleId IdType="pubmed">25173582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Babashah S, Sadeghizadeh M, Hajifathali A, Tavirani MR, Zomorod MS, Ghadiani M, et al.  Targeting of the signal transducer Smo links microRNA-326 to the oncogenic hedgehog pathway in CD34+ CML stem/progenitor cells. Int J Cancer. 2013;133:579–589. doi: 10.1002/ijc.28043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.28043</ArticleId>
            <ArticleId IdType="pubmed">23341351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao D, Cui Z. MicroRNA-361-3p regulates retinoblastoma cell proliferation and stemness by targeting hedgehog signaling. Exp Ther Med. 2019;17:1154–1162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6327618</ArticleId>
            <ArticleId IdType="pubmed">30679988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun K, Deng HJ, Lei ST, Dong JQ, Li GX. miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened. World J Gastroenterol. 2013;19:2197–2207. doi: 10.3748/wjg.v19.i14.2197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v19.i14.2197</ArticleId>
            <ArticleId IdType="pmc">PMC3627884</ArticleId>
            <ArticleId IdType="pubmed">23599646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang XH, Chen JS, Wang Q, Chen XL, Wen L, Chen LZ, et al.  miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol. 2011;225:463–472. doi: 10.1002/path.2877.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.2877</ArticleId>
            <ArticleId IdType="pubmed">21671467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seidl C, Panzitt K, Bertsch A, Brcic L, Schein S, Mack M, et al.  MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2. Cancer Lett. 2020;469:266–276. doi: 10.1016/j.canlet.2019.10.044.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canlet.2019.10.044</ArticleId>
            <ArticleId IdType="pubmed">31697978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Z, Huang C, Hao D. MicroRNA-1271 inhibits proliferation and promotes apoptosis of multiple myeloma cells through inhibiting smoothened-mediated hedgehog signaling pathway. Oncol Rep. 2017;37:1261–1269. doi: 10.3892/or.2016.5304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/or.2016.5304</ArticleId>
            <ArticleId IdType="pubmed">27959416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haque I, Kawsar HI, Motes H, Sharma M, Banerjee S, Banerjee SK, et al. Downregulation of miR-506-3p facilitates EGFR-TKI resistance through induction of sonic hedgehog signaling in non-small-cell lung cancer cell lines. Int J Mol Sci. 2020;21:9307.</Citation>
        </Reference>
        <Reference>
          <Citation>Cao D, Yu T, Ou X. MiR-873-5P controls gastric cancer progression by targeting hedgehog-GLI signaling. Pharmazie. 2016;71:603–606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29441930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang HQ, Sun Y, Li JQ, Huang LM, Tan SS, Yang FY, et al.  The expression of microRNA-324-3p as a tumor suppressor in nasopharyngeal carcinoma and its clinical significance. Onco Targets Ther. 2017;10:4935–4943. doi: 10.2147/OTT.S144223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/OTT.S144223</ArticleId>
            <ArticleId IdType="pmc">PMC5644595</ArticleId>
            <ArticleId IdType="pubmed">29066913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang XL, Shi HJ, Wang JP, Tang HS, Cui SZ. MiR-218 inhibits multidrug resistance (MDR) of gastric cancer cells by targeting hedgehog/smoothened. Int J Clin Exp Pathol. 2015;8:6397–6406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4525849</ArticleId>
            <ArticleId IdType="pubmed">26261515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma J, Zhou C, Chen X. miR-636 inhibits EMT, cell proliferation and cell cycle of ovarian cancer by directly targeting transcription factor Gli2 involved in hedgehog pathway. Cancer Cell Int. 2021;21:64. doi: 10.1186/s12935-020-01725-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12935-020-01725-7</ArticleId>
            <ArticleId IdType="pmc">PMC7819188</ArticleId>
            <ArticleId IdType="pubmed">33472614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wen SY, Lin Y, Yu YQ, Cao SJ, Zhang R, Yang XM, et al.  miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer. Oncogene. 2015;34:717–725. doi: 10.1038/onc.2014.9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2014.9</ArticleId>
            <ArticleId IdType="pubmed">24608427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J, Qiu M, An Y, Huang J, Gong C. miR-7-5p acts as a tumor suppressor in bladder cancer by regulating the hedgehog pathway factor Gli3. Biochem Biophys Res Commun. 2018;503:2101–2107. doi: 10.1016/j.bbrc.2018.07.166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2018.07.166</ArticleId>
            <ArticleId IdType="pubmed">30100065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xin L, Liu L, Liu C, Zhou LQ, Zhou Q, Yuan YW, et al.  DNA-methylation-mediated silencing of miR-7-5p promotes gastric cancer stem cell invasion via increasing Smo and Hes1. J Cell Physiol. 2020;235:2643–2654. doi: 10.1002/jcp.29168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.29168</ArticleId>
            <ArticleId IdType="pubmed">31517391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu L, Liu H, Yan Z, Sun Z, Luo S, Lu Q. Inhibition of the hedgehog signaling pathway suppresses cell proliferation by regulating the Gli2/miR-124/AURKA axis in human glioma cells. Int J Oncol. 2017;50:1868–1878. doi: 10.3892/ijo.2017.3946.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/ijo.2017.3946</ArticleId>
            <ArticleId IdType="pubmed">28393219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun J, Wang D, Li X, Yan J, Yuan X, Wang W. Targeting of miR-150 on Gli1 gene to inhibit proliferation and cell cycle of esophageal carcinoma EC9706. Cancer Biomark. 2017;21:203–210. doi: 10.3233/CBM-170658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/CBM-170658</ArticleId>
            <ArticleId IdType="pubmed">29081413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farahani M, Rubbi C, Liu L, Slupsky JR, Kalakonda N. CLL Exosomes modulate the Transcriptome and behaviour of recipient stromal cells and are selectively enriched in miR-202-3p. PLoS One. 2015;10:e0141429. doi: 10.1371/journal.pone.0141429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0141429</ArticleId>
            <ArticleId IdType="pmc">PMC4625016</ArticleId>
            <ArticleId IdType="pubmed">26509439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu Y, Zhang B, Wang B, Wu D, Wang C, Gao Y, et al.  MiR-144-3p inhibits gastric cancer progression and stemness via directly targeting GLI2 involved in hedgehog pathway. J Transl Med. 2021;19:432. doi: 10.1186/s12967-021-03093-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12967-021-03093-w</ArticleId>
            <ArticleId IdType="pmc">PMC8521984</ArticleId>
            <ArticleId IdType="pubmed">34657624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang N, Li P, Liu W, Wang N, Lu Z, Feng J, et al.  miR-141-3p suppresses proliferation and promotes apoptosis by targeting GLI2 in osteosarcoma cells. Oncol Rep. 2018;39:747–754.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29251328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma C, Nong K, Wu B, Dong B, Bai Y, Zhu H, et al.  miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1. J Exp Clin Cancer Res. 2014;33:54. doi: 10.1186/1756-9966-33-54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1756-9966-33-54</ArticleId>
            <ArticleId IdType="pmc">PMC4085644</ArticleId>
            <ArticleId IdType="pubmed">24961235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Zhang D, Chen C, Ruan Z, Li Y, Huang Y. MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. Mol Biol Cell. 2012;23:1423–1434. doi: 10.1091/mbc.e11-09-0777.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1091/mbc.e11-09-0777</ArticleId>
            <ArticleId IdType="pmc">PMC3327317</ArticleId>
            <ArticleId IdType="pubmed">22357618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng Y, Zhang X, Lin H, Deng S, Qin Y, He J, et al.  Dual activation of hedgehog and Wnt/β-catenin signaling pathway caused by downregulation of SUFU targeted by miRNA-150 in human gastric cancer. Aging (Albany NY) 2021;13:10749–10769. doi: 10.18632/aging.202895.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/aging.202895</ArticleId>
            <ArticleId IdType="pmc">PMC8064165</ArticleId>
            <ArticleId IdType="pubmed">33848981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munoz JL, Rodriguez-Cruz V, Ramkissoon SH, Ligon KL, Greco SJ, Rameshwar P. Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level. Oncotarget. 2015;6:1190–1201. doi: 10.18632/oncotarget.2778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.2778</ArticleId>
            <ArticleId IdType="pmc">PMC4359226</ArticleId>
            <ArticleId IdType="pubmed">25595896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miao X, Gao H, Liu S, Chen M, Xu W, Ling X, et al.  Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells. Int J Biol Macromol. 2018;106:234–240. doi: 10.1016/j.ijbiomac.2017.07.184.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijbiomac.2017.07.184</ArticleId>
            <ArticleId IdType="pubmed">28780419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long H, Wang Z, Chen J, Xiang T, Li Q, Diao X, et al.  microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu) Oncotarget. 2015;6:38705–38718. doi: 10.18632/oncotarget.5478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.5478</ArticleId>
            <ArticleId IdType="pmc">PMC4770731</ArticleId>
            <ArticleId IdType="pubmed">26462018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang L, Yin L, Zhang D, Wang C, Li G, Tan C, et al.  MicroRNA-221 promotes tumor progression by targeting HHIP in human glioblastoma. Transl Cancer Res. 2021;10:1073–1081. doi: 10.21037/tcr-21-99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21037/tcr-21-99</ArticleId>
            <ArticleId IdType="pmc">PMC8799047</ArticleId>
            <ArticleId IdType="pubmed">35116434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu N, Kadota M, Liu H, Abnet CC, Su H, Wu H, et al.  Genomic landscape of somatic alterations in esophageal squamous cell carcinoma and gastric cancer. Cancer Res. 2016;76:1714–1723. doi: 10.1158/0008-5472.CAN-15-0338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-15-0338</ArticleId>
            <ArticleId IdType="pmc">PMC4873357</ArticleId>
            <ArticleId IdType="pubmed">26857264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen S, Wang Y, Ni C, Meng G, Sheng X. HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells. Biomed Pharmacother. 2016;83:898–904. doi: 10.1016/j.biopha.2016.08.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2016.08.004</ArticleId>
            <ArticleId IdType="pubmed">27522003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med. 2018;22:5768–5775. doi: 10.1111/jcmm.13866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jcmm.13866</ArticleId>
            <ArticleId IdType="pmc">PMC6237607</ArticleId>
            <ArticleId IdType="pubmed">30188595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robinson EK, Covarrubias S, Carpenter S. The how and why of lncRNA function: An innate immune perspective. Biochim Biophys Acta Gene Regul Mech. 2020;1863:194419. doi: 10.1016/j.bbagrm.2019.194419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbagrm.2019.194419</ArticleId>
            <ArticleId IdType="pmc">PMC7185634</ArticleId>
            <ArticleId IdType="pubmed">31487549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Zhang XJ, Ji YX, Zhang P, Deng KQ, Gong J, et al.  The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy. Nat Med. 2016;22:1131–1139. doi: 10.1038/nm.4179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.4179</ArticleId>
            <ArticleId IdType="pmc">PMC5053883</ArticleId>
            <ArticleId IdType="pubmed">27618650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Engreitz JM, Haines JE, Perez EM, Munson G, Chen J, Kane M, et al.  Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature. 2016;539:452–455. doi: 10.1038/nature20149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature20149</ArticleId>
            <ArticleId IdType="pmc">PMC6853796</ArticleId>
            <ArticleId IdType="pubmed">27783602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dykes IM, Emanueli C. Transcriptional and post-transcriptional gene regulation by Long non-coding RNA. Genom Proteom Bioinform. 2017;15:177–186. doi: 10.1016/j.gpb.2016.12.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gpb.2016.12.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96–118. doi: 10.1038/s41580-020-00315-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41580-020-00315-9</ArticleId>
            <ArticleId IdType="pmc">PMC7754182</ArticleId>
            <ArticleId IdType="pubmed">33353982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36:5661–5667. doi: 10.1038/onc.2017.184.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2017.184</ArticleId>
            <ArticleId IdType="pmc">PMC6450570</ArticleId>
            <ArticleId IdType="pubmed">28604750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan Z, Xiu C, Liu D, Zhou G, Yang H, Pei R, et al.  Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis. J Cell Physiol. 2019;234:23111–23122. doi: 10.1002/jcp.28874.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.28874</ArticleId>
            <ArticleId IdType="pubmed">31131448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Song L, Ye Y, Li W. Long noncoding RNA DIO3OS hinders cell malignant behaviors of hepatocellular carcinoma cells through the microRNA-328/Hhip Axis. Cancer Manag Res. 2020;12:3903–3914. doi: 10.2147/CMAR.S245990.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CMAR.S245990</ArticleId>
            <ArticleId IdType="pmc">PMC7259459</ArticleId>
            <ArticleId IdType="pubmed">32547226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng S, Li M, Miao K, Xu H. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling. J Cell Biochem. 2020;121:2225–2235. doi: 10.1002/jcb.29445.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.29445</ArticleId>
            <ArticleId IdType="pubmed">31692053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu F, Li H, Hu C. LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer. Biosci Rep. 2019;39:BSR20180551.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu X, Zhao T, Bai X, Li M, Ren J, Wang M, et al.  LOC101930370/MiR-1471 Axis modulates the hedgehog signaling pathway in breast cancer. Cell Physiol Biochem. 2018;48:1139–1150. doi: 10.1159/000491980.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000491980</ArticleId>
            <ArticleId IdType="pubmed">30041193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J, Zhang Q, Fan X, Mo W, Dai W, Feng J, et al.  The long noncoding RNA TUG1 acts as a competing endogenous RNA to regulate the hedgehog pathway by targeting miR-132 in hepatocellular carcinoma. Oncotarget. 2017;8:65932–65945. doi: 10.18632/oncotarget.19582.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.19582</ArticleId>
            <ArticleId IdType="pmc">PMC5630383</ArticleId>
            <ArticleId IdType="pubmed">29029483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Q, Wang XJ, Jin JH. SOX2-induced upregulation of lncRNA LINC01510 promotes papillary thyroid carcinoma progression by modulating miR-335/SHH and activating hedgehog pathway. Biochem Biophys Res Commun. 2019;520:277–283. doi: 10.1016/j.bbrc.2019.09.138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2019.09.138</ArticleId>
            <ArticleId IdType="pubmed">31590919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan X, Tan J, Tao T, Zhang X, Weng Y, Weng X, et al.  LINC01123 enhances osteosarcoma cell growth by activating the hedgehog pathway via the miR-516b-5p/Gli1 axis. Cancer Sci. 2021;112:2260–2271. doi: 10.1111/cas.14913.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cas.14913</ArticleId>
            <ArticleId IdType="pmc">PMC8177773</ArticleId>
            <ArticleId IdType="pubmed">33837611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun C, Xiao T, Xiao Y, Li Y. Silencing of long non-coding RNA NEAT1 inhibits hepatocellular carcinoma progression by downregulating SMO by sponging microRNA-503. Mol Med Rep. 2021;23:168.</Citation>
        </Reference>
        <Reference>
          <Citation>Xia Y, Zhen L, Li H, Wang S, Chen S, Wang C, et al.  MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger hedgehog pathway. Cell Death Dis. 2021;12:326. doi: 10.1038/s41419-021-03494-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-021-03494-1</ArticleId>
            <ArticleId IdType="pmc">PMC7997896</ArticleId>
            <ArticleId IdType="pubmed">33771969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xing Z, Lin A, Li C, Liang K, Wang S, Liu Y, et al.  lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell. 2014;159:1110–1125. doi: 10.1016/j.cell.2014.10.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2014.10.013</ArticleId>
            <ArticleId IdType="pmc">PMC4266991</ArticleId>
            <ArticleId IdType="pubmed">25416949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Yin Z, Xu L, Liu H, Jiang L, Liu S, et al.  Upregulation of LINC01426 promotes the progression and stemness in lung adenocarcinoma by enhancing the level of SHH protein to activate the hedgehog pathway. Cell Death Dis. 2021;12:173. doi: 10.1038/s41419-021-03435-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-021-03435-y</ArticleId>
            <ArticleId IdType="pmc">PMC7875967</ArticleId>
            <ArticleId IdType="pubmed">33568633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J, Zhu P, Lu T, Du Y, Wang Y, He L, et al.  The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of hedgehog signaling. J Hepatol. 2019;70:918–929. doi: 10.1016/j.jhep.2018.12.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2018.12.015</ArticleId>
            <ArticleId IdType="pubmed">30582981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo K, Gong W, Wang Q, Gu G, Zheng T, Li Y, et al.  LINC01106 drives colorectal cancer growth and stemness through a positive feedback loop to regulate the Gli family factors. Cell Death Dis. 2020;11:869. doi: 10.1038/s41419-020-03026-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-020-03026-3</ArticleId>
            <ArticleId IdType="pmc">PMC7567881</ArticleId>
            <ArticleId IdType="pubmed">33067422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bo C, Li X, He L, Zhang S, Li N, An Y. A novel long noncoding RNA HHIP-AS1 suppresses hepatocellular carcinoma progression through stabilizing HHIP mRNA. Biochem Biophys Res Commun. 2019;520:333–340. doi: 10.1016/j.bbrc.2019.09.137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2019.09.137</ArticleId>
            <ArticleId IdType="pubmed">31604528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bai JY, Jin B, Ma JB, Liu TJ, Yang C, Chong Y, et al.  HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma. Cancer Lett. 2021;498:70–79. doi: 10.1016/j.canlet.2020.10.031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.canlet.2020.10.031</ArticleId>
            <ArticleId IdType="pubmed">33157157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai AY, Wade PA. Cancer biology and NuRD: a multifaceted chromatin remodelling complex. Nat Rev Cancer. 2011;11:588–596. doi: 10.1038/nrc3091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc3091</ArticleId>
            <ArticleId IdType="pmc">PMC4157524</ArticleId>
            <ArticleId IdType="pubmed">21734722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martínez-Jiménez F, Muiños F, Sentís I, Deu-Pons J, Reyes-Salazar I, Arnedo-Pac C, et al.  A compendium of mutational cancer driver genes. Nat Rev Cancer. 2020;20:555–572. doi: 10.1038/s41568-020-0290-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41568-020-0290-x</ArticleId>
            <ArticleId IdType="pubmed">32778778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato K, Hitomi Y, Imamura K, Esumi H. Hyperstable U1snRNA complementary to the K-ras transcripts induces cell death in pancreatic cancer cells. Br J Cancer. 2002;87:898–904. doi: 10.1038/sj.bjc.6600563.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjc.6600563</ArticleId>
            <ArticleId IdType="pmc">PMC2376165</ArticleId>
            <ArticleId IdType="pubmed">12373606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, et al.  Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366:2171–2179. doi: 10.1056/NEJMoa1113713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1113713</ArticleId>
            <ArticleId IdType="pmc">PMC5278761</ArticleId>
            <ArticleId IdType="pubmed">22670903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taipale J, Chen JK, Cooper MK, Wang B, Mann RK, Milenkovic L, et al.  Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine. Nature. 2000;406:1005–1009. doi: 10.1038/35023008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35023008</ArticleId>
            <ArticleId IdType="pubmed">10984056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lauth M, Bergström A, Shimokawa T, Toftgård R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci U S A. 2007;104:8455–8460. doi: 10.1073/pnas.0609699104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0609699104</ArticleId>
            <ArticleId IdType="pmc">PMC1866313</ArticleId>
            <ArticleId IdType="pubmed">17494766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Javed Z, Javed Iqbal M, Rasheed A, Sadia H, Raza S, Irshad A, et al.  Regulation of hedgehog signaling by miRNAs and Nanoformulations: A possible therapeutic solution for colorectal cancer. Front Oncol. 2020;10:607607. doi: 10.3389/fonc.2020.607607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2020.607607</ArticleId>
            <ArticleId IdType="pmc">PMC7817854</ArticleId>
            <ArticleId IdType="pubmed">33489917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov. 2021;20:629–651. doi: 10.1038/s41573-021-00219-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41573-021-00219-z</ArticleId>
            <ArticleId IdType="pmc">PMC8212082</ArticleId>
            <ArticleId IdType="pubmed">34145432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mao W, Wang K, Xu B, Zhang H, Sun S, Hu Q, et al.  ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma. Mol Cancer. 2021;20:142. doi: 10.1186/s12943-021-01443-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12943-021-01443-2</ArticleId>
            <ArticleId IdType="pmc">PMC8570002</ArticleId>
            <ArticleId IdType="pubmed">34740354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oshima G, Guo N, He C, Stack ME, Poon C, Uppal A, et al.  In vivo delivery and therapeutic effects of a MicroRNA on colorectal liver metastases. Mol Ther. 2017;25:1588–1595. doi: 10.1016/j.ymthe.2017.04.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ymthe.2017.04.005</ArticleId>
            <ArticleId IdType="pmc">PMC5498809</ArticleId>
            <ArticleId IdType="pubmed">28457664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin Y, Zhang B, Wang W, Fei B, Quan C, Zhang J, et al.  miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A. Clin Cancer Res. 2014;20:6187–6199. doi: 10.1158/1078-0432.CCR-14-1030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-14-1030</ArticleId>
            <ArticleId IdType="pubmed">25294901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong BS, Ryu HS, Kim N, Kim J, Lee E, Moon H, et al.  Tumor suppressor miRNA-204-5p regulates growth, metastasis, and immune microenvironment remodeling in breast cancer. Cancer Res. 2019;79:1520–1534. doi: 10.1158/0008-5472.CAN-18-3511.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-18-3511</ArticleId>
            <ArticleId IdType="pubmed">30737233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhuang Z, Yu P, Xie N, Wu Y, Liu H, Zhang M, et al.  MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma. Theranostics. 2020;10:1433–1453. doi: 10.7150/thno.38507.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.38507</ArticleId>
            <ArticleId IdType="pmc">PMC6956807</ArticleId>
            <ArticleId IdType="pubmed">31938073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang H, Liu Y, Qiu Y, Ding M, Zhang Y. MiRNA-204-5p and oxaliplatin-loaded silica nanoparticles for enhanced tumor suppression effect in CD44-overexpressed colon adenocarcinoma. Int J Pharm. 2019;566:585–593. doi: 10.1016/j.ijpharm.2019.06.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijpharm.2019.06.020</ArticleId>
            <ArticleId IdType="pubmed">31181310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uz M, Kalaga M, Pothuraju R, Ju J, Junker WM, Batra SK, et al.  Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer. J Control Release. 2019;294:237–246. doi: 10.1016/j.jconrel.2018.12.031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jconrel.2018.12.031</ArticleId>
            <ArticleId IdType="pmc">PMC6379902</ArticleId>
            <ArticleId IdType="pubmed">30576747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Brien K, Breyne K, Ughetto S, Laurent LC, Breakefield XO. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol. 2020;21:585–606. doi: 10.1038/s41580-020-0251-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41580-020-0251-y</ArticleId>
            <ArticleId IdType="pmc">PMC7249041</ArticleId>
            <ArticleId IdType="pubmed">32457507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu L, Huang J, Mo J, Da X, Li Q, Fan M, et al.  Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis. Cell Mol Biol Lett. 2022;27:17. doi: 10.1186/s11658-022-00309-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s11658-022-00309-9</ArticleId>
            <ArticleId IdType="pmc">PMC8903597</ArticleId>
            <ArticleId IdType="pubmed">35193488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si K, et al.  Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnol. 2020;18:10. doi: 10.1186/s12951-019-0563-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12951-019-0563-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar V, Mondal G, Dutta R, Mahato RI. Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis. Biomaterials. 2016;76:144–156. doi: 10.1016/j.biomaterials.2015.10.047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2015.10.047</ArticleId>
            <ArticleId IdType="pubmed">26524535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang H, Zhu Q, Cheng J, Wu Y, Fan M, Zhang J, et al.  Opposite regulation of Wnt/β-catenin and Shh signaling pathways by Rack1 controls mammalian cerebellar development. Proc Natl Acad Sci U S A. 2019;116:4661–4670. doi: 10.1073/pnas.1813244116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1813244116</ArticleId>
            <ArticleId IdType="pmc">PMC6410857</ArticleId>
            <ArticleId IdType="pubmed">30765517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Si-Tu J, Cai Y, Feng T, Yang D, Yuan S, Yang X, et al.  Upregulated circular RNA circ-102004 that promotes cell proliferation in prostate cancer. Int J Biol Macromol. 2019;122:1235–1243. doi: 10.1016/j.ijbiomac.2018.09.076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijbiomac.2018.09.076</ArticleId>
            <ArticleId IdType="pubmed">30219508</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
